S1791 Validating Calibration of an Artificial Intelligence Assessment of Endoscopic Severity in Ulcerative Colitis

Introduction: Regulatory guidance recommends the endoscopy subscore as the index to assess the endoscopic component of the primary endpoint in ulcerative colitis (UC) trials. Inter-reader variability in assessments may impact the reliability of trial results. Currently, there is no metric in place to assess the certainty by which a reader is assigning an endoscopy subscore. Machine learning (ML) provides an opportunity to assess the endoscopy subscore and provide a measurement of its certainty in a standardized manner. Artificial Intelligence Assessment of Endoscopic Severity (AI-ES) accurately assesses the endoscopy subscore. The objective of this study is to evaluate the calibration of AI-ES - how well its predicted probabilities reflect true likelihoods - to assess the reliability of its measurement of certainty in endoscopy subscore assessments in UC trials. Methods: AI-ES is a deep learning algorithm that assesses the endoscopy subscore in UC endoscopic videos. AI-ES measures probability for the 4 ordinal endoscopy subscore classes. The endoscopy subscore with the highest probability is assigned as the final score by AI-ES. We assessed calibration on a holdout test set of 639 videos (∼25%) from the Phase 3 induction trial for mirikizumab in UC (NCT03518086). Videos had a 2 + 1 centrally read endoscopy subscore, randomly selected from week 0 and 12 with a distribution of endoscopic severity similar to the overall study population. Calibration plots were generated across endoscopy subscore classes with probabilities grouped into septiles (∼100 videos per group) for primary analysis and deciles for confirmation. Brier scores, ranging from 0 (perfect calibration) to 1 (worst calibration), were calculated, with values <0.25 considered informative. Results: AI-ES demonstrated strong calibration, with Brier scores below <0.25 for each endoscopy subscore (0: 0.037, 1: 0.082, 2: 0.162, 3: 0.112). The Brier score for evaluation of endoscopic improvement (0,1 vs 2,3) also showed excellent calibration (0.066). Findings were consistent when assessing probabilities by deciles. Conclusion: Whereas data on the certainty of human readers in endoscopy subscore assessments are elusive, AI-ES is calibrated across all endoscopy subscore classes, providing reliable data on score probabilities. This novel measurement of certainty by AI-ES added to the score assessment may enable novel AI-based multi-reader or consensus workflows in trials, potentially improving the reliability of UC endpoint assessments.

Authors

Publication Details

Journal
The American Journal of Gastroenterology
Published
2025-10-01
DOI
https://doi.org/10.14309/01.ajg.0001134624.08679.a3
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

S1791 Validating Calibration of an Artificial Intelligence Assessment of Endoscopic Severity in Ulcerative Colitis

Shrujal S. Baxi, Chakib Battioui, Mohammad Haft‐Javaherian, Josh Lehrer et al.
The American Journal of Gastroenterology
Inflammatory Bowel Disease
article

S1791 Validating Calibration of an Artificial Intelligence Assessment of Endoscopic Severity in Ulcerative Colitis

Shrujal S. Baxi, Chakib Battioui, Mohammad Haft‐Javaherian, Josh Lehrer, Klaus Gottlieb, Pavel Brodskiy, Daniel Colucci, Evan Y. Yu, Darren Thomason, William Eastman, Walter Reinisch, D Onken
article en

Abstract

Introduction: Regulatory guidance recommends the endoscopy subscore as the index to assess the endoscopic component of the primary endpoint in ulcerative colitis (UC) trials. Inter-reader variability in assessments may impact the reliability of trial results. Currently, there is no metric in place to assess the certainty by which a reader is assigning an endoscopy subscore. Machine learning (ML) provides an opportunity to assess the endoscopy subscore and provide a measurement of its certainty in a standardized manner. Artificial Intelligence Assessment of Endoscopic Severity (AI-ES) accurately assesses the endoscopy subscore. The objective of this study is to evaluate the calibration of AI-ES - how well its predicted probabilities reflect true likelihoods - to assess the reliability of its measurement of certainty in endoscopy subscore assessments in UC trials. Methods: AI-ES is a deep learning algorithm that assesses the endoscopy subscore in UC endoscopic videos. AI-ES measures probability for the 4 ordinal endoscopy subscore classes. The endoscopy subscore with the highest probability is assigned as the final score by AI-ES. We assessed calibration on a holdout test set of 639 videos (∼25%) from the Phase 3 induction trial for mirikizumab in UC (NCT03518086). Videos had a 2 + 1 centrally read endoscopy subscore, randomly selected from week 0 and 12 with a distribution of endoscopic severity similar to the overall study population. Calibration plots were generated across endoscopy subscore classes with probabilities grouped into septiles (∼100 videos per group) for primary analysis and deciles for confirmation. Brier scores, ranging from 0 (perfect calibration) to 1 (worst calibration), were calculated, with values <0.25 considered informative. Results: AI-ES demonstrated strong calibration, with Brier scores below <0.25 for each endoscopy subscore (0: 0.037, 1: 0.082, 2: 0.162, 3: 0.112). The Brier score for evaluation of endoscopic improvement (0,1 vs 2,3) also showed excellent calibration (0.066). Findings were consistent when assessing probabilities by deciles. Conclusion: Whereas data on the certainty of human readers in endoscopy subscore assessments are elusive, AI-ES is calibrated across all endoscopy subscore classes, providing reliable data on score probabilities. This novel measurement of certainty by AI-ES added to the score assessment may enable novel AI-based multi-reader or consensus workflows in trials, potentially improving the reliability of UC endpoint assessments.

The American Journal of GastroenterologyVol. 120(10S2)
Openalex Percentile: Top 59%
Inflammatory Bowel Disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.